Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)

被引：0
|
作者：
Baiba Hedegaard Hansen
Jamal Abed Hanash
Alice Rasmussen
Jørgen Fischer Hansen
Morten Birket-Smith
机构：
[1] Bispebjerg University Hospital,Liaison Psychiatry Unit, Psychiatric Centre Bispebjerg
[2] Bispebjerg University Hospital,Department of Cardiology
[3] University Hospital of Copenhagen Rigshospitalet,Department of Psychiatry
来源：
Trials | / 10卷
关键词：
Percutaneous Coronary Intervention; Acute Coronary Syndrome; Heart Rate Variability; Selective Serotonin Reuptake Inhibitor; Escitalopram;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
    Davidson, JRT
    Bose, A
    Korotzer, A
    Zheng, HJ
    DEPRESSION AND ANXIETY, 2004, 19 (04) : 234 - 240
  • [42] Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
    Harada, E.
    Kato, M.
    Fujikoshi, S.
    Wohlreich, M. M.
    Berggren, L.
    Tokuoka, H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (10) : 1139 - 1148
  • [43] Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study
    Gommoll, Carl
    Forero, Giovanna
    Mathews, Maju
    Nunez, Rene
    Tang, Xiongwen
    Durgam, Suresh
    Sambunaris, Angelo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 297 - 306
  • [44] Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study
    Verrico, Christopher D.
    Haile, Colin N.
    Mahoney, James J., III
    Thompson-Lake, Daisy G. Y.
    Newton, Thomas F.
    De La Garza, Richard, II
    DRUG AND ALCOHOL DEPENDENCE, 2014, 141 : 72 - 78
  • [45] A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    Garakani, Amir
    Martinez, Jose M.
    Marcus, Sue
    Weaver, James
    Rickels, Karl
    Fava, Maurizio
    Hirschowitz, Jack
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (05) : 269 - 275
  • [46] ESCITALOPRAM RESPONSE IS ASSOCIATED WITH CHANGES IN ENDOCANNABINOID SIGNALING IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Strawn, Jeffrey
    Mills, Jeffrey
    Schroeder, Heidi
    Marusak, Hilary
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 311 - 312
  • [47] Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial
    Kaosombatwattana, Uayporn
    Pongprasobchai, Supot
    Limsrivilai, Julajak
    Maneerattanaporn, Monthira
    Leelakusolvong, Somchai
    Tanwandee, Tawesak
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (02) : 411 - 417
  • [48] Design and Methodology for the Korean Observational and Escitalopram Treatment Studies of Depression in Acute Coronary Syndrome: K-DEPACS and EsDEPACS
    Kim, Jae-Min
    Bae, Kyung-Yeol
    Kang, Hee-Ju
    Kim, Sung-Wan
    Shin, Il-Seon
    Hong, Young-Joon
    Kim, Ju-Han
    Shin, Hee-Young
    Ahn, YoungKeun
    Kim, Jong-Keun
    Jeong, Myung-Ho
    Yoon, Jin-Sang
    PSYCHIATRY INVESTIGATION, 2014, 11 (01) : 89 - 94
  • [49] A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study
    Ik-Kyung Jang
    Veronica Pettigrew
    Michael H. Picard
    Peter R. Kowey
    Valentin Demmel
    Michael R. Zile
    Jun Tatsuno
    Frans J. Th. Wackers
    Mark Hibberd
    Journal of Thrombosis and Thrombolysis, 2005, 20 : 147 - 153
  • [50] A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Rationale and design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) study
    Jang, IK
    Pettigrew, V
    Picard, MH
    Kowey, PR
    Demmel, V
    Zile, MR
    Tatsuno, J
    Wackers, FJT
    Hibberd, M
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 20 (03) : 147 - 153
12345